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ABSTRACT
Background: A Step I diet with lean beef compared with lean white
meat both decrease LDL cholesterol. To our knowledge, no studies
have evaluated a low–saturated fatty acid (SFA) (,7% calories) diet
that contains lean beef.
Objective: We studied the effect on LDL cholesterol of cholesterol-
lowering diets with varying amounts of lean beef [ie, Dietary Ap-
proaches to Stop Hypertension (DASH): 28 g beef/d; Beef in an
Optimal Lean Diet (BOLD): 113 g beef/d; and Beef in an Optimal
Lean Diet plus additional protein (BOLD+): 153 g beef/d] com-
pared with that of a healthy American diet (HAD).
Design: Thirty-six hypercholesterolemic participants (with LDL-
cholesterol concentrations .2.8 mmol/L) were randomly assigned to con-
sume each of the 4 diets (HAD: 33% total fat, 12% SFA, 17% protein, and
20 g beef/d), DASH (27% total fat, 6% SFA, 18% protein, and 28 g beef/d),
BOLD (28% total fat, 6% SFA, 19% protein, and 113 g beef/d), and
BOLD+ (28% total fat, 6% SFA, 27% protein, and 153 g beef/d) for 5 wk.
Results: There was a decrease in total cholesterol (TC) and LDL-
cholesterol concentrations (P , 0.05) after consumption of the DASH
(20.49 6 0.11 and 20.37 6 0.09 mmol/L, respectively), BOLD
(20.48 6 0.10 and 20.35 6 0.9 mmol/L, respectively), and BOLD+
(20.50 6 0.10 and 20.345 6 0.09 mmol/L, respectively) diets
compared with after consumption of the HAD (20.22 6 0.10 and
20.14 6 0.10 mmol/L, respectively). Apolipoprotein A-I, C-III, and
C-III bound to apolipoprotein A1 particles decreased after BOLD
and BOLD+ diets compared with after the HAD, and there was a
greater decrease in apolipoprotein B after consumption of the BOLD+
diet than after consumption of the HAD (P , 0.05 for both). LDL
cholesterol and TC decreased after consumption of the DASH, BOLD,
and BOLD+ diets when the baseline C-reactive protein (CRP) concen-
tration was ,1 mg/L; LDL cholesterol and TC decreased when baseline
CRP concentration was .1 mg/L with the BOLD and BOLD+ diets.
Conclusions: Low-SFA, heart-healthy dietary patterns that contain lean
beef elicit favorable effects on cardiovascular disease (CVD) lipid and
lipoprotein risk factors that are comparable to those elicited by a DASH
dietary pattern. These results, in conjunction with the beneﬁcial effects
on apolipoprotein CVD risk factors after consumption of the BOLD and
BOLD+ diets, which were greater with the BOLD+ diet, provide support
for including lean beef in a heart-healthy dietary pattern. This trial was
registered at clinicaltrials.gov as NCT00937898. Am J Clin Nutr
2012;95:9–16.
INTRODUCTION
The recommended approach for lowering LDL cholesterol,
which is a primary target for CVD
4 risk reduction, is to reduce
dietary SFA (,7% of energy), trans fatty acids (as low as
possible), and cholesterol (,200 mg/d) (1). A dietary pattern
that emphasizes fruit and vegetables, legumes, whole grains,
nuts, and seeds is recommended (2). Skim and reduced-fat dairy
products, moderate amounts of lean-protein sources, including
meats, poultry, and eggs, and increased seafood (particularly
fatty ﬁsh), as well as plant-based proteins also are recommended
(2). It is not necessary to exclude lean beef, and the Adult
Treatment Panel III Guidelines and the Dietary Guidelines for
Americans indicate that lean red meat can be included in a heart-
healthy dietary pattern that is low in SFA and cholesterol (1, 2).
Beef is a popular food and a source of many nutrients, and,
consequently, lean beef can be an important lean-protein food
source to meet current food-based and nutrient recommendations.
Epidemiologic studies have reported mixed associations be-
tween red-meat consumption and CVD mortality (3), acute
myocardial infarction, unstable angina, and metabolic syndrome
(3–8). A recent report from the Nurses’ Health Study showed that
the replacement of one serving of unprocessed red meat with
poultry or ﬁsh was associated with 19% and 24% reductions
in coronary heart disease risk, respectively (5). Some of the
discrepancies in the literature may reﬂect not differentiating
higher-fat red meat from lean red meat (speciﬁcally beef) or not
accounting for different meat processing and cooking methods
(6) because some epidemiologic studies have not shown this
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only red, and not processed, meat was included in the analysis (7).
Previous free-living and controlled-consumption studies re-
ported comparable LDL cholesterol–lowering effects of a Na-
tional Cholesterol Education Program Step I diet (total fat ,30%
and SFA ,10% energy) (9) with lean beef or lean white meat
(10–12). To our knowledge, no studies have examined the ef-
fects of an SFA-restricted (,7% calories), heart-healthy diet
with lean beef. Red meat is limited in the DASH diet as
a strategy to decrease SFA (13).
The cholesterol-lowering effects of a low-SFA diet with lean
beef have not been rigorously evaluated. Thus, we conducted
a well-controlled consumption study to evaluate the LDL
cholesterol–lowering effects of a DASH-like diet that contained
lean beef (BOLD diet: 28% total fat, 6% SFA, 54% carbohy-
drates,19%protein,and113gbeef/d,andamoderateproteindiet
that contained lean beef (BOLD+: 28% total fat, 6% SFA, 45%
carbohydrates, 27% protein, and 153 g beef/d) compared with
a healthy American control diet in individuals with elevated
LDL-cholesterol concentrations. A DASH diet was included
because it is the gold standard for contemporary dietary rec-
ommendations. Because Erlinger et al (14) showed that moderate
elevations in CRP concentrations attenuated lipid-lowering
responses to diet, we also examined this relation.
SUBJECTS AND METHODS
Subjects
Healthy men and women (30–65 y of age) with elevated LDL-
cholesterol concentrations (2.84–4.55 mmol/L) were recruited.
Additional inclusion criteria were as follows: BMI (in kg/m
2)o f
18.5–37, triglycerides concentration ,3.95 mmol/L, and blood
pressure ,140/90 mm Hg. Participants were allowed to take
prescribed blood pressure–lowering medications and were eli-
gible as long as their blood pressure was below the entry criteria.
All participants were nonsmokers and free of established CVD,
stroke, diabetes, liver, kidney, or autoimmune disease. Exclusion
criteria included the use of cholesterol and lipid-lowering
medications or supplements (psyllium, ﬁsh oil, soy lecithin, and
phytoestrogens), pregnancy or lactation, weight loss  10% of
body weight within the 6 mo before enrollment in the study, and
vegetarianism. The Institutional Review Board at the Pennsyl-
vania State University approved the experimental protocol, and
all subjects provided written informed consent. This trial was
registered at clinicaltrials.gov as NCT00937898.
Study design
The study used a 4-period randomized, crossover, controlled-
feeding design. Subjects were randomly assigned to a treatment
(diet) order; they consumed 4 diets (HAD and DASH, BOLD,
and BOLD+ diets) for 5 wk each. A short compliance break
(average of 1 wk) separated the diet periods. At the beginning
of the study and at the end of each diet period, on 2 consecutive
days, subjects completed a series of clinical and physical as-
sessments (ie, blood draw, height, and weight measurements) at
theGeneralClinical Research Center.The ﬁrstparticipants began
the study in September 2007; the last participant completed the
study in March 2009.
Diets
The nutrient composition of experimental diets is presented in
Table 1. Total energy was held constant for each participant
throughout the 4-diet periods, and participants were monitored
(daily weigh-ins) to ensure they remained weight stable. The 3
experimental diets (DASH, BOLD, and BOLD+ diets) contained
similar amounts of total fat, SFA, PUFA, and cholesterol. The
HAD was higher in total fat, SFA, MUFA, PUFA, and cho-
lesterol and was lower in total ﬁber. BOLD and DASH diets
were matched for macronutrient composition. The BOLD+ diet
was higher in protein (27% of total energy) compared with
the HAD (17%), DASH (18%), and BOLD (19%) diets and,
thus, lower in carbohydrates (45% compared with 50–55%)
(Table 1).
The HAD providedfull-fat cheese anddairy products,moreoil
and butter, and reﬁned grains. The DASH, BOLD, and BOLD+
diets provided low-fat or nonfat versions of these foods, less oil
and butter, and more whole grains. All diets were rich in fruit,
vegetables, and lean meats consistent with food-based dietary
recommendations. Although matched for protein, the BOLD and
DASH diets differed in their primary protein source; the BOLD
diet included an average of 113 g lean beef/d. The BOLD+ diet
contained 153 g lean beef/d, and the HAD and DASH diet
contained 20 and 28 g lean beef/d, respectively.
The lean beef used in the study (primarily select-grade top
round, chuck shoulder pot roast, and 95% lean ground beef) was
purchased from The Pennsylvania State University Meats Lab-
oratory. The meat was prepared via braising, grilling, or frying
(95% lean ground beef only) and never over an open ﬂame to
prevent charring.
Menus were created for a 6-d diet cycle across a range of
calorie amounts (1800–3600 kcal/d). Sample 1-d menus for each
of the diets are shown in Table 2. All meals and snacks were
prepared at the Metabolic Diet Study Center, The Pennsylvania
State University. Participants ate one meal per day (Monday–
Friday) in the Center, and their other meals were prepared and
packed for off-site consumption. Adherence with the diets was
monitored via daily and weekly compliance questionnaires.
Clinical assessments
Bodyweightwasmeasuredateachlaboratoryvisit(inaddition
to daily weigh-ins at the diet center). All blood samples were
collected after an overnight (10–12 h) fast according to a stan-
dardized protocol. Serum and plasma aliquots were stored at
280C until the time of analysis.
Lipids, lipoproteins, and apolipoproteins
TC and triglycerides were measured by using enzymatic
procedures with commercially available kits (cholesterol and
triglyceride kits; Alfa Wassermann). HDL cholesterol was quan-
tiﬁed according to the modiﬁed heparin-manganese precipitation
procedure of Warnick and Albers (15). LDL cholesterol was de-
termined by using Friedewald’s equation as follows:
LDL cholesterol = TC 2 HDL cholesterol + (triglycerides 4 5) ð1Þ
Theseassayswereconductedatthecoreendocrinelaboratory
at the MS Hershey Medical Center General Clinical Research
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measured by using the immunoturbidimetric procedure of
Riopponen et al (16) with corresponding monospeciﬁc poly-
clonal antisera. These assays were conducted at the Oklahoma
Research Institute (Oklahoma City, OK) under the supervision
of Petar Alaupovic.
Insulin and glucose
Insulin was measured by using a radioimmunoassay with
125I-labeled human insulin and a human insulin antiserum (17).
Glucose was determined with an immobilized enzyme biosensor
for glucose (YSI 2300 STAT Plus Glucose & Lactate Analyzer;
Yellow Springs Instruments) (18). These assays were conducted
at the core endocrine laboratory at the MS Hershey Medical
Center.
High-sensitivity CRP
CRP was measured with the use of latex-enhanced immuno-
nephelometry (Quest Diagnostics).
Statistical analysis
Power calculations were conducted to estimate the required
sample size on the basis of data from the original DASH study
(19) in which LDL cholesterol was reduced by 9% after 8 wk
consumption of the DASH diet compared with after consumption
of the control diet. Analyses used the following assumptions:
power was set at 0.8, a was set at 0.05, and 2-tailed tests were
used. It was estimated that a sample size of 40 was sufﬁcient to
test the primary LDL-cholesterol hypothesis while allowing for
a 10% dropout rate.
All statistical analyses were performed with SAS software
(version 9.2; SAS Institute Inc). Two-sample t tests were used
to determine signiﬁcant differences between sexes at baseline
for each outcome variable. The residuals for each variable were
used to assess normality. Logarithmic transformations were used
for nonnormally distributed variables (triglycerides). The mixed-
models procedure (PROC MIXED) in the SAS software (version
9.2; SAS Institute Inc) was used to test the effects of diet and
order on outcome variables. A doubly repeated measures ANCOVA
(repeated for diet and day of blood draw) was used with age,
weight, and baseline lipid concentrations as covariates for lipid
and lipoprotein measurements. Repeated ANCOVA (repeated
for diet) was used with age, weight, and baseline amounts for the
remaining variables. The primary outcome was the change in
LDL cholesterol after consumption of the BOLD and BOLD+
diets compared with after consumption of the HAD; Dunnett’s
post hoc test was used to determine whether these differences
were signiﬁcant (P , 0.05). Tukey-Kramer–adjusted P values
were used to determine whether differences between the diets in
secondary outcome variables were signiﬁcant (P , 0.05). In the
TABLE 1
BOLD study diets: energy, nutrient composition, and food-group servings
1
Diets
HAD DASH BOLD BOLD+
Nutrient targets
Calories 2097 2106 2100 2104
Protein (g; percentage of kcal) 17 (91.7) 18 (98.4) 19 (99.6) 27 (145.6)
Carbohydrates (g; percentage of kcal) 50 (268.1) 55 (298.3) 54 (287.4) 45 (243.7)
Fat (g; percentage of kcal) 33 (77.0) 27 (64.4) 28 (65.8) 28 (66.6)
Cholesterol (mg) 287 188 168 193
SFA (g; percentage of kcal) 12 (27.9) 6 (15.2) 6 (15.4) 6 (14.5)
PUFA (g; percentage of kcal) 7 (15.5) 8 (18.9) 7 (16.5) 7 (16.1)
MUFA (g; percentage of kcal) 11 (25.9) 9 (21.8) 11 (25.2) 12 (29.3)
Fiber (g) 24 36 32 38
Sodium (mg) 3243 2982.8 2712 3344
Potassium (mg) 3259 4247 3998 4417
Calcium (mg) 993 1140 936 1060
Magnesium (mg) 308 403 392 429
Food groups (servings/d)
Fruit and juices (cups) 3.1 4.1 4.5 3.4
Vegetables (cups) 3.2 4.3 3.9 4.6
Grains (oz) 8.3 4.5 5.6 5.3
Low-fat dairy products (cups) 1.2 2.3 1.8 4.7
High-fat dairy products (cups) 0.7 0.1 0.0 0.0
Legumes, nuts, seeds, and other vegetable protein (oz) 0.6 2.1 1.3 4.2
Beef (oz) 0.7 1.0 4.0 5.4
Poultry, pork, and ﬁsh (oz) 3.7 3.7 1.0 1.0
Egg and egg-product substitutes (oz) 0.24 0.2 0.1 0.9
Fats and oils (g) 5.4 4.0 4.3 1.4
1 On the basis of 2100 kcal/d. Average across a 6-d menu cycle. All values were determined by using Nutritionist Pro
software (Axxya Systems LLC). BOLD, Beef in an Optimal Lean Diet; BOLD+, Beef in an Optimal Lean Diet plus
additional protein; DASH, Dietary Approaches to Stop Hypertension; HAD, healthy American diet; SFA, saturated fatty
acid.
LEAN BEEF AND CVD RISK 11secondary analysis of CRP subgroups, P values were Bonferroni-
adjusted for multiple comparisons; Tukey-Kramer–adjusted
P values were not used to control for overadjustment because of
erroneous comparisons.
RESULTS
Forty-two individuals were recruited for the study. During the
study, one subject dropped out because of a job change and
relocation, one subject dropped out because of an unrelated
illness, and 4 subjects dropped out because of inability to adhere
to the dietary protocol. A total of 36 subjects were included in the
ﬁnal analysis (Figure 1).
Baseline subject characteristics are presented in Table 3.
Women had signiﬁcantly higher serum TC (5.74 compared with
5.02 mmol/L; P = 0.003), LDL cholesterol (3.78 compared with
3.31 mmol/L; P = 0.02), and HDL cholesterol (1.45 compared
with 1.16 mmol/L; P = 0.01) concentrations than did men. Men
had signiﬁcantly higher BMI (27.3 compared with 24.8; P =
0.02) and serum glucose (4.82 compared with 4.6 mmol/L; P =
0.03) concentrations compared with women. Despite these dif-
ferences at baseline, no signiﬁcant interactions of sex by out-
come measure were shown. Subject adherence to the prescribed
diets was 93% according to daily self-reporting forms. Body
weight was maintained during the diet periods within 2.2 kg.
Lipids, lipoproteins, and apolipoproteins
TC, LDL cholesterol, and HDL cholesterol were signiﬁcantly
decreased after consumption of the DASH, BOLD, and BOLD+
diets but not the HAD diet (P , 0.05) (Table 4). Compared with
the HAD, LDL cholesterol was signiﬁcantly decreased by 5.5%,
4.7%, and 4.4% by the DASH, BOLD, and BOLD+ diets, re-
spectively (P , 0.05; Figure 2). TC was decreased after con-
sumption of the DASH, BOLD, and BOLD+ diets by 3.8%,
3.8%, and 4.6%, respectively, compared with after consumption
of the HAD. There were no differences in any of the lipid and li-
poprotein changes in the test diets (DASH, BOLD, and BOLD+)
(P . 0.1).
Apolipoprotein A-I was signiﬁcantly decreased after con-
sumption of the BOLD and BOLD+ diets compared with after
consumption of the HAD (130.6 and 130.1 compared with 135.9
mg/dL, respectively), with no signiﬁcant differences after con-
sumptionoftheDASHdiet(133.7mg/dL).ApolipoproteinBwas
signiﬁcantly decreased after consumption of the BOLD+ diet
than after consumption of the HAD (88.6 compared with 92.8
mg/dL). There were no signiﬁcant differences in the A1:apoli-
poprotein B ratio for the DASH, BOLD, or BOLD+ diets
compared with that for the HAD. Apolipoprotein C-III concen-
trations were signiﬁcantly decreased after consumption of the
BOLD+diet(7.7mg/dL)comparedwithafterconsumptionofthe
HAD (8.5 mg/dL) and DASH (8.2 mg/dL) diets. Apolipoprotein
C-III concentrations were also signiﬁcantly decreased after
consumption of the BOLD diet (7.9 mg/dL) but not after con-
sumption of the DASH diet compared with after consumption of
the HAD (Table 5). Apolipoprotein C-III HS concentrations
were decreased after consumption of the BOLD (5.4 mg/dL) and
BOLD+ (5.3 mg/dL) diets compared with after consumption
of the HAD (5.8 mg/dL, P , 0.05). No signiﬁcant differences
were observed with heparin-precipitated apolipoprotein C-III
concentrations or apolipoprotein C-III ratio (apolipoprotein
C-III HS to heparin-precipitated apolipoprotein C-III) during
this intervention.
TABLE 2
One-day DASH, BOLD, and BOLD+ menus
1
HAD DASH BOLD BOLD+
Breakfast Oatmeal packet Whole-grain cereal and milk Oatmeal packet Whole-grain cereal and milk
Brown sugar
Orange juice
Milk
English mufﬁn
Butter
Yogurt
Banana
Orange juice
Blueberries (frozen)
Orange juice
Milk
Plain bagel and margarine
Orange juice
Low-fat cottage cheese
Lunch Tuna salad
Pita bread
Baby carrots
Pretzels
Vegetarian chili
Whole-wheat crackers
Low-fat cheddar cheese
Peaches, canned in juice
Meatballs and marinara sauce
Sandwich roll and lettuce
Broccoli, baby carrots, and
ranch dressing
Pretzels
Beef chili with shredded
cheddar cheese
Whole-wheat crackers
Peaches, canned in juice
Dinner Southwest fajita
with chicken
Flour tortillas
Cheddar cheese
(shredded)
Lettuce
Red bell pepper
Sour cream
Turkey breast with mashed
potatoes and gravy
Broccoli
Lettuce, cherry tomatoes,
and ﬂax tahini dressing
Dinner roll with butter
Southwest fajita with beef
Flour tortillas, cheddar cheese
(shredded), lettuce, and red
bell pepper
Pot roast with mashed potatoes
and gravy
Broccoli and edamame beans
Lettuce, cherry tomatoes, and ﬂax
tahini dressing
Dinner roll with margarine
Snack Chocolate-chip
cookies
Trail mix
Grapes
Peanut butter
Apple
Celery sticks
Hummus
Whole-wheat pita and baby carrots
for dipping
Trail mix
1 BOLD, Beef in an Optimal Lean Diet; BOLD+, Beef in an Optimal Lean Diet plus additional protein; DASH, Dietary Approaches to Stop Hyper-
tension; HAD, healthy American diet.
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There were no differences in CRP after consumption of any of
the dietary treatments (Table 6). Secondary analysis revealed
that baseline CRP concentrations affected TC and the LDL-
cholesterol responses of subjects to the dietary treatments (diet ·
baseline CRP; P , 0.05). Subjects with baseline CRP concen-
trations  1 mg/L experienced signiﬁcant decreases in TC from
baseline after consumption of the BOLD and BOLD+ diets.
These changes were greater than after consumption of the HAD
diet. In addition, the changes were greater after consumption of
the BOLD diet than after consumption of the DASH diet.
Similar effects of CRP were observed for LDL cholesterol; in-
dividuals with baseline CRP concentrations  1 mg/L had sig-
niﬁcant decreases in LDL cholesterol after consumption of the
BOLD and BOLD+ diets, although these were not different from
after consumption of the HAD (P = 0.052 and P = 0.087, re-
spectively) or DASH (P = 0.098 and P = 0.999, respectively)
diets (Table 6).
In comparison, in individuals with baseline CRP concen-
trations ,1 mg/L, TC was signiﬁcantly decreased after con-
sumption of all 4 diets; the TC reduction was greatest for the
DASH diet, and this was signiﬁcantly different from that for the
HAD but not different from that for the BOLD or BOLD+ diets.
In the low-CRP subgroup (,1 mg/L), the experimental diets
(not the HAD) signiﬁcantly decreased LDL cholesterol; only
differences between the HAD and DASH diet were signiﬁcant
(Table 6).
Glucose and insulin
Serum glucose and insulin concentrations were not different
after consumption of the DASH (4.76 6 0.05 mmol/L and 12.0 6
0.06 lU/mL, respectively), BOLD (4.82 6 0.05 mmol/L and
13.6 6 0.5 lU/mL, respectively), or BOLD+ (4.92 6 0.05
mmol/L and 13.6 6 0.6 lU/mL, respectively) diets compared
with after consumption of the HAD (4.82 6 0.05 mmol/L and
12.6 6 0.6 lU/mL, respectively).
DISCUSSION
Lipids, lipoproteins, and apolipoproteins
To our knowledge, this was the ﬁrst controlled-consumption
study that showed an increase in lean-beef consumption while
controlling SFA (6% calories) in the context of a heart-healthy
dietwasassociatedwithsigniﬁcantdecreasesinLDLcholesterol.
In the current study, the BOLD and DASH diets decreased
the LDL-cholesterol concentration by 20.41 mmol/L compared
with similar decreases, compared with baseline, of 20.34 mg/dL
and 20.30 mmol/L in the DASH (19) and OmniHeart (carbo-
hydrate diet) (20) trials, respectively. In addition, the decrease
in the LDL-cholesterol concentration for the BOLD+ and
OmniHeart protein diets was similar at 20.42 mg/dL and 20.36
mmol/L, respectively. Decreases in LDL-cholesterol concen-
trations observed for the BOLD and BOLD+ diets were ach-
ieved with protein sources that differed from those used in the
FIGURE 1. Recruitment ﬂow diagram.
TABLE 3
Baseline characteristics of study participants (n = 36)
1
Characteristic Men (n = 15) Women (n = 21) Combined
Age (y) 49 6 1.8 (39-63) 50 6 2.0 (45-97) 50 6 1.4
BMI (kg/m
2) 27.3 6 0.7 (19.4–35.5) 24.8 6 0.5 (19.4–35.5)
2 25.7 6 0.5
TC (mmol/L) 5.02 6 0.14 (3.98–6.16) 5.74 6 0.22 (4.58–7.38)
2 5.46 6 0.12
LDL cholesterol (mmol/L) 3.31 6 0.14 (2.46–2.46) 3.78 6 0.12 (3.00–4.84)
2 3.6 6 0.1
HDL cholesterol (mmol/L) 1.16 6 0.05 (0.91–1.55) 1.45 6 0.08 (0.88–2.30)
2 1.34 6 0.06
Non–HDL cholesterol 3.87 6 0.14 (3.04–5.05) 4.28 6 0.13 (3.43–5.33)
2 4.11 6 0.19
TG (mmol/L) 1.18 6 0.10 (0.55–1.88) 1.07 6 0.06 (0.68–1.95) 1.12 6 0.05
Glucose (mmol/L) 4.82 6 0.10 (3.83–5.55) 4.60 6 0.08 (4.05–5.38)
2 4.7 6 0.09
Insulin (IU/mL) 12 6 1.9 (7-23) 13 6 0.961 (9-17) 12 6 0.97
CRP (mg/L) 1.43 6 0.4 (5.4–0.3) 1.34 6 0.3 (4.5–0.3) 1.4 6 0.2
1 All values are means 6 SEMs; ranges in parentheses. Baseline values were measured before consuming any study
food. CRP, C-reactive protein; TC, total cholesterol; TG, triglycerides.
2 Two-sample t test was used to determine signiﬁcant (P , 0.05) differences between sexes with SAS (version 9.2;
SAS Institute Inc).
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(0.9 servings of beef, pork, or ham/d studies. However, SFA con-
centrations were similar in the DASH, OmniHeart, and BOLD
study diets (7%, 6%, and 6% of total calories, respectively).
HDL cholesterol decreased during the DASH (1.2 mmol/L),
BOLD (1.2 mmol/L), and BOLD+ (1.2 mmol/L) diets compared
with during the HAD (1.3 mmol/L); these decreases were due to
differences in total and saturated fat between diets (total fat:
33% compared with 28%; SFA: 12% compared with 6%). Thus,
the protein source [with the exception of soy protein (21)] does
not appear to modify the TC or LDL cholesterol response to
a cholesterol-lowering diet.
TheLDL-cholesteroldecreasesweobservedextendtheﬁndings
of studies conducted by Davidson et al (11) and Hunninghake et al
(10) with free-living subjects who were instructed to substitute
lean beef for chicken, ﬁsh, or pork in a National Cholesterol
Education Program Step I diet (,30% total fat, ,10% SFA, and
,300 mg cholesterol/d). Subjects who consumed the BOLD diet
experienced a greater decrease in TC (29.3%) and LDL cho-
lesterol (210.1%) (compared with consumption of the HAD)
from baseline than reported by Davidson et al (21.0% and 21.7%
respectively) and Hunninghake et al (20.9% and 21.9%, re-
spectively). These differences most likely were due to the lower
SFA intake after consumption of the BOLD diet (6% SFA). In
a controlled-consumption study conducted by Beauchesen-
Rondeau et al (12) to evaluate the substitution of lean beef com-
pared with chicken or white ﬁsh, the decrease in LDL cholesterol
(27.0%) was not as great as that (210.1%) with the BOLD diet.
Again, this result may reﬂect differences in the SFA content of the
experimental diets (10% compared with 6%) compared with the
control diets between studies [BOLD study: 6% compared with
12%; Beauchesen-Rondeau et al (12): 10% compared with 12%].
Despite the greater magnitude of the LDL-cholesterol decrease in
our study than in some previous studies (10, 11), a key consistent
ﬁnding (from our study and in the literature) is the equivalent de-
creases in LDL cholesterol with lean beef than with white meat
when macronutrient proﬁles of diets are similar.
Compared with the HAD, the BOLD+ diet was the only
treatment diet that signiﬁcantly decreased apolipoprotein B.
Compared with the HAD, both lean-beef diets signiﬁcantly de-
creased apolipoprotein A1 and total apolipoprotein C-III. Smit
et al (22), by using NHANES (phase 1) data, reported that the
highest quartile of apolipoprotein B was associated with the
highest intakes of beef. However, SFAwas highly correlated with
theproteinsource,which,thus,preventedconclusionsfrombeing
drawn on the basis of individual predictors (ie, beef or SFA). Our
results concurred with the apolipoprotein B ﬁndings from the
OmniHeart trial in which the moderate protein diet yielded the
greatest decrease inapolipoprotein B.Mensinket al (23)reported
thatanisocaloricsubstitution(1%ofenergy)ofcarbohydratesfor
MUFA and PUFA but not SFA decreased apolipoprotein B;
however, isocaloric substitution of protein for carbohydrate also
decreases apolipoprotein B; the extent of this effect has yet to be
fully quantiﬁed.
Changes in total apolipoprotein C-III on lean-beef diets re-
ﬂected decreases in apolipoprotein C-III HS, which represents
the number of apolipoprotein C-III molecules bound to apoli-
poprotein A1–containing particles (Table 5). Kawakami and
Yoshida (24) have suggested that apolipoprotein C-III bound to
HDL inhibits the antiinﬂammatory properties of HDL. Although
total apolipoprotein A1 was decreased in the BOLD and BOLD+
diets, the decrease in apolipoprotein C-III bound to apolipo-
protein A1–containing particles suggested that the antiinﬂam-
matory capacity of the apolipoprotein A1–containing particles
was improved.
TABLE 4
Effect of diet on lipids and lipoproteins
1
HAD
(n = 33)
DASH
(n = 35)
BOLD
(n = 34)
BOLD+
(n = 34)
TC (mmol/L) 5.25 6 0.09
a 4.98 6 0.09
b 4.99 6 0.09
b 4.96 6 0.09
b
TG (mmol/L)
2 1.06 6 0.06 1.08 6 0.06 1.05 6 0.07 1.00 6 0.05
LDL cholesterol (mmol/L) 3.44 6 0.08
a 3.22 6 0.07
b 3.23 6 0.07
b 3.23 6 0.07
b
HDL cholesterol (mmol/L) 1.32 6 0.05
a 1.22 6 0.04
b 1.24 6 0.04
b 1.24 6 0.04
b
Non-HDL cholesterol (mmol/L) 3.89 6 0.07
a 3.71 6 0.08
b 3.70 6 0.08
b 3.66 6 0.07
b
1 All values are means 6 SEMs. The MIXED procedure (version 9.2; SAS Institute Inc) was used to test the effects of
diet. Values in the same row with different superscript letters are signiﬁcantly different (Dunnett-adjusted P , 0.05).
BOLD, Beef in an Optimal Lean Diet; BOLD+, Beef in an Optimal Lean Diet plus additional protein; DASH, Dietary
Approaches to Stop Hypertension; HAD, healthy American diet; TC, total cholesterol; TG, triglycerides.
2 Raw values reported. Data were log transformed to achieve normality when testing for signiﬁcant differences.
FIGURE 2. Change in lipids and lipoproteins. Mean percentage change
(6SEM) from the HAD (HAD: n = 33; DASH: n = 35; BOLD: n = 34; and
BOLD+: n = 34). The MIXED procedure in SAS software (version 9.2; SAS
Institute Inc) was used to test the effects of diet. *Signiﬁcantly different from
the HAD, P , 0.05. BOLD, Beef in an Optimal Lean Diet; BOLD+, Beef in
an Optimal Lean Diet plus additional protein; DASH, Dietary Approaches to
Stop Hypertension; HAD, healthy American diet; TC, total cholesterol; TG,
triglycerides.
14 ROUSSELL ET ALBaseline CRP concentrations appeared to inﬂuence TC and
LDL cholesterol responses of subjects to the experimental diets.
The link between inﬂammation and lipid and lipoprotein changes
has been known for several decades (25, 26); however, the
mechanism by which CRP modulates these responses is un-
known. Previous studies have reported a blunted TC- and LDL
cholesterol–lowering response to DASH (14) and Step I (27, 28)
diets in individuals with increased baseline CRP. However, we
observed a different effect in the high-CRP group for diets that
contained lean beef. We observed a greater decrease in TC
(compared with in the DASH diet) and LDL cholesterol (com-
paredwithzero)withconsumptionofBOLDandBOLD+dietsin
subjects with high CRP concentrations. In subjects with high
CRP, the BOLD and BOLD+ diets signiﬁcantly decreased
concentrations of TC (20.53 and 20.54 mmol/L, respectively)
and LDL cholesterol (20.38 and 20.39 mmol/L respectively)
similarly. The mechanisms that account for these different diet
responses in subjects with high compared with low CRP are not
clear. Additional studies are needed to determine whether diets
that contain lean beef beneﬁt individuals with high CRP to
achieve a substantial cholesterol-lowering diet response.
The BOLD study has several strengths. We conducted a tightly
controlled clinical study and achieved high levels of dietary ad-
herence as veriﬁed by the daily monitoring forms. To our knowl-
edge, the BOLD study is ﬁrst study to examine the effects of
increased lean-beef consumption in the context of current dietary
recommendations. Finally, our study population was representative
of a large portion of the US population [LDL-cholesterol con-
centrations in approximately the 35th percentile (1)], and thus, the
ﬁndings have broad applicability. A limitation of our study was that
we had only self-reported compliance measures and no biological
measures of adherence to the lean beef and other test diets. In
addition, we used a controlled-consumption study design and lean
beef was preselected for, prepared for, and consumed by partic-
ipants. In a free-living setting, individuals would be required to
select lean cuts of beef from a wide variety of options in the
marketplace and be mindful of preparation techniques and portion
control. Although there are 29 cuts of beef that meet lean beef
criteria, many grocery stores would feature the following cuts: top
loin and top round steaks, top sirloin bottom round roast, and 95%
lean ground beef. Adhering to the BOLD and BOLD+ diets that we
prepared might be challenging for consumers, at least initially, and
therefore, decreases in LDL-cholesterol concentrations would be
less than expected. It is important for consumers to be mindful of
the types of cut, preparation techniques, and portion control. For
many individuals, this can be challenging, which would lessen the
expected LDL cholesterol–lowering response.
Inconclusion, the inclusion ofleanbeef (113g/d) orthe partial
replacement of carbohydrates with protein (including lean beef)
in a low-SFA, DASH-like diet signiﬁcantly decreased TC and
LDLcholesterolcomparedwithinaHAD.Thesereductionswere
similar in magnitude to those observed for the DASH diet. The
TABLE 5
Effect of diet on apolipoproteins
1
Apolipoprotein HAD DASH BOLD BOLD+
A-I (mg/dL) 135.9 6 2.1
a 133.73 6 2.1
a,b 130.6 6 1.2
b 130.11 6 2.1
b
B (mg/dL) 92.8 6 1.5
a 91.0 6 1.5
a,b 91.1 6 1.5
a,b 88.6 6 1.5
b
C-III (mg/dL) 8.5 6 0.2
a 8.21 6 0.2
a,b 7.94 6 0.2
b,c 7.71 6 0.2
c
C-III HP (mg/dL) 2.62 6 0.1 2.6 6 0.1 2.5 6 0.1 2.43 6 0.1
C-III HS (mg/dL) 5.83 6 0.2
a 5.59 6 0.2
a,b 5.4 6 0.1
b 5.30 6 0.2
b
1 All values are means 6 SEMs. The MIXED procedure (version 9.2; SAS Institute Inc) was used to test the effects of
diet. Values in the same row with different superscript letters are signiﬁcantly different (Tukey-adjusted P , 0.05). BOLD,
Beef in an Optimal Lean Diet; BOLD+, Beef in an Optimal Lean Diet plus additional protein; DASH, Dietary Approaches
to Stop Hypertension; HAD, healthy American diet; HP, heparin precipitated; HS, heparin supernatant ﬂuid.
TABLE 6
Effect of diet on CRP, TC, and LDL-cholesterol change
1
HAD DASH BOLD BOLD+
CRP (mg/L) 1.14 6 0.19 1.07 6 0.15 1.0 6 0.18 0.92 6 0.09
TC-change (mmol/L)
Baseline CRP
,1 mg/L (n = 21) 20.35 6 0.13
a,2 20.73 6 0.13
b,2 20.47 6 0.13
a,b,2 20.49 6 0.13
a,b,2
 1 mg/L (n = 15) 20.08 6 0.14
a 20.20 6 0.14
a,b 20.53 6 0.13
b,c,2 20.54 6 0.14
b,2
LDL-cholesterol change (mmol/L)
Baseline CRP
,1 mg/L (n = 21) 20.19 6 0.08
a 20.47 6 0.10
b,2 20.29 6 0.08
a,2 20.31 6 0.10
a,2
 1 mg/L (n = 15) 20.07 6 0.13
a 20.21 6 0.13
a 20.38 6 0.13
a,2 20.39 6 0.16
a,2
1 All values are means 6 SEMs. CRP stratiﬁcation was based on American Heart Association CRP cutoffs (29).
Changes are from baseline. There was no signiﬁcant effect of diet (P , 0.05) on CRP concentrations. Diet · baseline CRP,
P = 0.0008 (LDL-cholesterol change) and P = 0.0009 (TC change). CRP was log transformed to achieve normality. Actual
values of CRP are presented. Values in the same row with different superscript letters are signiﬁcantly different, adjusted
P , 0.05 (MIXED procedure, version 9.2; SAS Institute Inc). BOLD, Beef in an Optimal Lean Diet; BOLD+, Beef in an
Optimal Lean Diet plus additional protein; CRP, C-reactive protein; DASH, Dietary Approaches to Stop Hypertension;
HAD, healthy American diet; TC, total cholesterol.
2 Signiﬁcantly different from zero (P , 0.05) (MIXED procedure, version 9.2; SAS Institute Inc).
LEAN BEEF AND CVD RISK 15speciﬁc effects of the moderate protein, BOLD+ diet on apoli-
poprotein B and C-III merit additional study. These effects could
reﬂect the increased lean-beef, total protein, or reduced carbo-
hydrate content of the BOLD+ diet; additional research is needed
to determine the role of each of these components in the BOLD+
diet on CVD risk. The results of the BOLD study provide
convincing evidence that lean beef can be included in a heart-
healthy diet that meets current dietary recommendations and
reduces CVD risk.
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